Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA259756
Max Phase: Preclinical
Molecular Formula: C62H103NO49S
Molecular Weight: 1678.53
Molecule Type: Small molecule
Associated Items:
ID: ALA259756
Max Phase: Preclinical
Molecular Formula: C62H103NO49S
Molecular Weight: 1678.53
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1=N[C@@H]2[C@@H](O)[C@H](O[C@@H]3O[C@H](CO[C@H]4O[C@H](CO[C@H]5O[C@H](CO[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]6O)[C@@H](O)[C@H](O)[C@@H]5O)[C@@H](O)[C@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]6O)[C@@H]5O)[C@@H]4O)[C@@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)[C@@H]3O)[C@@H](CO)O[C@H]2S1
Standard InChI: InChI=1S/C62H103NO49S/c1-12-63-23-33(80)47(19(8-70)106-62(23)113-12)107-59-46(93)50(110-60-52(39(86)28(75)16(5-67)101-60)112-61-51(38(85)27(74)17(6-68)102-61)111-57-43(90)36(83)26(73)15(4-66)99-57)32(79)22(105-59)11-96-55-44(91)49(109-58-45(92)48(30(77)18(7-69)100-58)108-56-42(89)35(82)25(72)14(3-65)98-56)31(78)21(104-55)10-95-54-41(88)37(84)29(76)20(103-54)9-94-53-40(87)34(81)24(71)13(2-64)97-53/h13-62,64-93H,2-11H2,1H3/t13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23-,24-,25-,26-,27-,28-,29-,30-,31-,32-,33-,34+,35+,36+,37+,38+,39+,40+,41+,42+,43+,44+,45+,46+,47-,48+,49+,50+,51+,52+,53+,54+,55+,56+,57+,58+,59+,60+,61+,62+/m1/s1
Standard InChI Key: YRXPLJQBSXEGOW-LKDUVQOASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1678.53 | Molecular Weight (Monoisotopic): 1677.5319 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Li B, Takegawa K, Suzuki T, Yamamoto K, Wang LX.. (2008) Synthesis and inhibitory activity of oligosaccharide thiazolines as a class of mechanism-based inhibitors for endo-beta-N-acetylglucosaminidases., 16 (8): [PMID:18304822] [10.1016/j.bmc.2008.02.032] |
Source(1):